Research output per year
Research output per year
Personal profile
About
Dr. James J. Burke is an obstetrician-gynecologist in Savannah, Georgia and is affiliated with Memorial Health University Medical Center. He received his medical degree from Medical College of Georgia.
Related documents
Education/Academic qualification
Fellowship, The University Of Michigan
… → 1997
Residency, Northwestern University
… → 1994
MD, Medical College of Georgia
… → 1990
Research Interests
- Gynecologic Oncology
Disciplines
- Medicine and Health Sciences
- Obstetrics and Gynecology
Research output
- 7 Article
-
Concurrent, Extra-pelvic Endometriosis of the Umbilicus and Catamenial Pneumothorax
Rogers, D. R. & Burke, J., Jan 1 2021, In: OB-GYN.Research output: Contribution to journal › Article › peer-review
-
A collaborative pilot model among Georgia oncologists to strengthen clinical trial enrollment and promote equity of care for minorities.
Ghamande, S. A., Cantuaria, G., Jillella, A. P., Kota, V., Green, A. E., Richards, W., Burke, J. J., Zaren, H. A., Taylor, M. A., Reddy, S., Dillmon, M. S., Pippas, A. W., Schnell, F. M., Srinivasiah, J., McDonough, C. H., Short, J., Whitaker, G., Belgrave, A. & Paris, N. M., Jun 1 2018, In: Journal of Clinical Oncology. 36Research output: Contribution to journal › Article › peer-review
-
Quality of life (QoL) in a phase III trial of pelvic external beam radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk, early stage endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group study.
Vongruenigen, V., Huang, H. Q., Cella, D., Randall, M., Mannel, R. S., Kim, B.-G., Salani, R., Burke, J. J., Rutherford, T. J., Spirtos, N., Robison, K. & Wenzel, L. B., Jun 1 2018, In: Journal of Clinical Oncology. 36Research output: Contribution to journal › Article › peer-review
-
A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study
Randall, M., Filiaci, V., McMeekin, D., Yashar, C. M., Mannel, R., Salani, R., DiSilvestro, P., Burke, J., Rutherford, T., Spirtos, N., Cho, J., Kim, J., Anderson, P., Brewster, W., Small, W., Carney, M., Aghajanian, C. & Miller, D. S., Dec 1 2017, In: International Journal of Radiation Oncology Biology Physics. 99, 5Research output: Contribution to journal › Article › peer-review
-
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
Myers, A. P., Filiaci, V. L., Zhang, Y., Pearl, M., Behbakht, K., Makker, V., Hanjani, P., Zweizig, S., Burke, J. J., Downey, G., Leslie, K. K., Van Hummelen, P., Birrer, M. J. & Fleming, G. F., Apr 1 2016, In: Gynecologic Oncology. 141, 1Research output: Contribution to journal › Article › peer-review